SEC Form 4 · accession 0001209191-16-103894
BIOCEPT INC · BIOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lyle J Arnold
Officer — SR VP of R&D and CSO
Period of report
Feb 29, 2016
Accepted (ET)
Mar 1, 2016 · 4:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001044378
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $1.34 | Feb 29, 2016 | A | 25,000 | A | — | Feb 28, 2026 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F125% of the shares subject to the option shall vest on the first annual anniversary of the Vesting Commencement Date (2/29/16) with the balance vesting in equal monthly installments thereafter until fully vested on February 29, 2020.